Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Garima Sharma and Chiranjib Chakraborty.
Garima Sharma
Connection Strength
4.166
Chiranjib Chakraborty
  1. Advances in nanocarriers enabled brain targeted drug delivery across blood brain barrier. Int J Pharm. 2019 Mar 25; 559:360-372.
    View in: PubMed
    Score: 0.807
  2. Immunoinformatics Approach for the Identification and Characterization of T Cell and B Cell Epitopes towards the Peptide-Based Vaccine against SARS-CoV-2. Arch Med Res. 2021 05; 52(4):362-370.
    View in: PubMed
    Score: 0.232
  3. SARS-CoV-2 and other human coronaviruses: Mapping of protease recognition sites, antigenic variation of spike protein and their grouping through molecular phylogenetics. Infect Genet Evol. 2021 04; 89:104729.
    View in: PubMed
    Score: 0.231
  4. Ongoing Clinical Trials of Vaccines to Fight against COVID-19 Pandemic. Immune Netw. 2021 Feb; 21(1):e5.
    View in: PubMed
    Score: 0.231
  5. Immunoinformatics approach to understand molecular interaction between multi-epitopic regions of SARS-CoV-2 spike-protein with TLR4/MD-2 complex. Infect Genet Evol. 2020 11; 85:104587.
    View in: PubMed
    Score: 0.227
  6. Response to: Status of Remdesivir: Not Yet Beyond Question! Arch Med Res. 2021 01; 52(1):104-106.
    View in: PubMed
    Score: 0.226
  7. A SARS-CoV-2 vaccine candidate: In-silico cloning and validation. Inform Med Unlocked. 2020; 20:100394.
    View in: PubMed
    Score: 0.223
  8. COVID-19: Consider IL-6 receptor antagonist for the therapy of cytokine storm syndrome in SARS-CoV-2 infected patients. J Med Virol. 2020 11; 92(11):2260-2262.
    View in: PubMed
    Score: 0.222
  9. Extensive Partnership, Collaboration, and Teamwork is Required to Stop the COVID-19 Outbreak. Arch Med Res. 2020 10; 51(7):728-730.
    View in: PubMed
    Score: 0.221
  10. Consider TLR5 for new therapeutic development against COVID-19. J Med Virol. 2020 11; 92(11):2314-2315.
    View in: PubMed
    Score: 0.221
  11. Tocilizumab: A Therapeutic Option for the Treatment of Cytokine Storm Syndrome in COVID-19. Arch Med Res. 2020 08; 51(6):595-597.
    View in: PubMed
    Score: 0.221
  12. Probable Molecular Mechanism of Remdesivir for the Treatment of COVID-19: Need to Know More. Arch Med Res. 2020 08; 51(6):585-586.
    View in: PubMed
    Score: 0.220
  13. Development of epitope-based peptide vaccine against novel coronavirus 2019 (SARS-COV-2): Immunoinformatics approach. J Med Virol. 2020 06; 92(6):618-631.
    View in: PubMed
    Score: 0.218
  14. The novel strategies for next-generation cancer treatment: miRNA combined with chemotherapeutic agents for the treatment of cancer. Oncotarget. 2018 Feb 09; 9(11):10164-10174.
    View in: PubMed
    Score: 0.188
  15. miRNAs in Alzheimer Disease - A Therapeutic Perspective. Curr Alzheimer Res. 2017; 14(11):1198-1206.
    View in: PubMed
    Score: 0.175
  16. Micro-Environmental Signature of The Interactions between Druggable Target Protein, Dipeptidyl Peptidase-IV, and Anti-Diabetic Drugs. Cell J. 2017 Apr-Jun; 19(1):65-83.
    View in: PubMed
    Score: 0.174
  17. Regulatory functional territory of PLK-1 and their substrates beyond mitosis. Oncotarget. 2017 Jun 06; 8(23):37942-37962.
    View in: PubMed
    Score: 0.045
  18. Suppression of osteogenic activity by regulation of WNT and BMP signaling during titanium particle induced osteolysis. J Biomed Mater Res A. 2017 03; 105(3):912-926.
    View in: PubMed
    Score: 0.044
  19. The crucial role and regulations of miRNAs in zebrafish development. Protoplasma. 2017 Jan; 254(1):17-31.
    View in: PubMed
    Score: 0.041
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.